ASRS
NBIX icon

Arizona State Retirement System’s Neurocrine Biosciences NBIX Stock Holding History

Arizona State Retirement System’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Buy
27,337
+244
+0.9% +$36.2K 0.02% 485
2026
Q1 		$3.57M Sell
27,093
-133
-0.5% -$17.6K 0.02% 528
2025
Q4 		$3.86M Sell
27,226
-1,981
-7% -$287K 0.02% 517
2025
Q3 		$4.1M Buy
29,207
+321
+1% +$43.5K 0.02% 515
2025
Q2 		$3.63M Sell
28,886
-356
-1% -$40.8K 0.02% 523
2025
Q1 		$3.23M Sell
29,242
-60
-0.2% -$7.6K 0.02% 541
2024
Q4 		$4M Buy
29,302
+469
+2% +$58K 0.02% 500
2024
Q3 		$3.32M Buy
28,833
+1,499
+5% +$205K 0.02% 557
2024
Q2 		$3.76M Buy
27,334
+310
+1% +$42.5K 0.03% 476
2024
Q1 		$3.73M Buy
27,024
+185
+0.7% +$25.3K 0.03% 490
2023
Q4 		$3.54M Buy
26,839
+219
+0.8% +$25.2K 0.03% 491
2023
Q3 		$2.99M Buy
26,620
+4
+0% +$421 0.03% 504
2023
Q2 		$2.51M Sell
26,616
-1,333
-5% -$130K 0.02% 582
2023
Q1 		$2.83M Buy
27,949
+878
+3% +$91.4K 0.03% 550
2022
Q4 		$3.23M Buy
27,071
+829
+3% +$97.1K 0.03% 480
2022
Q3 		$2.79M Sell
26,242
-340
-1% -$34.5K 0.03% 509
2022
Q2 		$2.59M Buy
26,582
+175
+0.7% +$16.2K 0.03% 544
2022
Q1 		$2.48M Buy
26,407
+637
+2% +$54K 0.02% 605
2021
Q4 		$2.19M Sell
25,770
-763
-3% -$70.2K 0.02% 692
2021
Q3 		$2.54M Sell
26,533
-20
-0.1% -$1.89K 0.02% 617
2021
Q2 		$2.58M Buy
26,553
+962
+4% +$92.2K 0.02% 630
2021
Q1 		$2.49M Buy
25,591
+187
+0.7% +$19.6K 0.02% 635
2020
Q4 		$2.44M Sell
25,404
-1,440
-5% -$139K 0.02% 600
2020
Q3 		$2.58M Buy
26,844
+6,421
+31% +$743K 0.03% 532
2020
Q2 		$2.49M Buy
20,423
+289
+1% +$31.9K 0.04% 438
2020
Q1 		$1.74M Buy
+20,134
New +$1.97M 0.03% 506

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arizona State Retirement System's NBIX Position: Q2 2026 in Review

Arizona State Retirement System increased its Neurocrine Biosciences (NBIX) stake by 0.9% in Q2 2026, buying an estimated $36.2K and bringing the position to 27,337 shares worth $4.61M. The position accounts for 0.02% of the portfolio, ranked #485.

Arizona State Retirement System first reported a position in NBIX in Q1 2020 and has held it in 26 quarters since. 771 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Arizona State Retirement System held 27,337 shares of Neurocrine Biosciences worth $4.61M as of Q2 2026.
  • Arizona State Retirement System bought 244 Neurocrine Biosciences shares in Q2 2026, an estimated $36.2K.
  • Neurocrine Biosciences made up 0.02% of Arizona State Retirement System's portfolio in Q2 2026, its #485 holding.
  • Arizona State Retirement System first reported a position in Neurocrine Biosciences in Q1 2020 and has held it in 26 quarters since.
  • 771 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.